content: <?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
    <!-- Generated by Workiva -->
    <headerData>
      <submissionType>144</submissionType>
      <filerInfo>
        <filer>
          <filerCredentials>
            <cik>0001822629</cik>
            <ccc>XXXXXXXX</ccc>
          </filerCredentials>
        </filer>
        <liveTestFlag>LIVE</liveTestFlag>
  
  
  
      </filerInfo>
    </headerData>
    <formData>
      <issuerInfo>
        <issuerCik>0001023024</issuerCik>
        <issuerName>ANI Pharmaceuticals, Inc.</issuerName>
        <secFileNumber>001-31812</secFileNumber>
        <issuerAddress>
          <com:street1>210 Main Street West</com:street1>
          <com:city>Daudette</com:city>
          <com:stateOrCountry>MN</com:stateOrCountry>
          <com:zipCode>56623</com:zipCode>
        </issuerAddress>
        <issuerContactPhone>218-634-3500</issuerContactPhone>
        <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Nikhil S. Lalwani</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
        <relationshipsToIssuer>
          <relationshipToIssuer>President, CEO</relationshipToIssuer>
        </relationshipsToIssuer>
      </issuerInfo>
      <securitiesInformation>
        <securitiesClassTitle>Common</securitiesClassTitle>
        <brokerOrMarketmakerDetails>
          <name>JP Morgan Securities LLC</name>
          <address>
            <com:street1>390 Madison Avenue</com:street1>
            <com:street2>6th Floor</com:street2>
            <com:city>New York</com:city>
            <com:stateOrCountry>NY</com:stateOrCountry>
            <com:zipCode>10017</com:zipCode>
          </address>
        </brokerOrMarketmakerDetails>
        <noOfUnitsSold>11616</noOfUnitsSold>
        <aggregateMarketValue>708344</aggregateMarketValue>
        <noOfUnitsOutstanding>20280798</noOfUnitsOutstanding>
        <approxSaleDate>08/15/2023</approxSaleDate>
        <securitiesExchangeName>NASDAQ</securitiesExchangeName>
      </securitiesInformation>
      <securitiesToBeSold>
        <securitiesClassTitle>Common</securitiesClassTitle>
        <acquiredDate>08/15/2023</acquiredDate>
        <natureOfAcquisitionTransaction>Stock Option Exercise</natureOfAcquisitionTransaction>
        <nameOfPersonfromWhomAcquired>Issuer</nameOfPersonfromWhomAcquired>
        <isGiftTransaction>N</isGiftTransaction>
        <amountOfSecuritiesAcquired>11616</amountOfSecuritiesAcquired>
        <paymentDate>08/15/2023</paymentDate>
        <natureOfPayment>Cash</natureOfPayment>
      </securitiesToBeSold>
      <nothingToReportFlagOnSecuritiesSoldInPast3Months>N</nothingToReportFlagOnSecuritiesSoldInPast3Months>
      <securitiesSoldInPast3Months>
        <sellerDetails>
          <name>Nikhil S. Lalwani</name>
          <address>
            <com:street1>C/o ANI Pharmaceuticals, Inc.</com:street1>
            <com:street2>210 Main Street West</com:street2>
            <com:city>Daudette</com:city>
            <com:stateOrCountry>MN</com:stateOrCountry>
            <com:zipCode>56623</com:zipCode>
          </address>
        </sellerDetails>
        <securitiesClassTitle>Common</securitiesClassTitle>
        <saleDate>08/11/2023</saleDate>
        <amountOfSecuritiesSold>56666</amountOfSecuritiesSold>
        <grossProceeds>3272462</grossProceeds>
      </securitiesSoldInPast3Months>
      <remarks>The options to be exercised within 3 months from the date of this filing.</remarks>
      <noticeSignature>
        <noticeDate>08/15/2023</noticeDate>
        <signature>/s/ J.P. Morgan Securities LLC as agent and attorney-in-fact for Nikhil S. Lalwani</signature>
      </noticeSignature>
    </formData>
  </edgarSubmission>
metadata_documents: [{"type": "144", "sequence": "1", "filename": "primary_doc.xml", "secsgml_size_bytes": 3612}]
text: 144
  0001822629
  XXXXXXXX
  LIVE
  0001023024
  ANI Pharmaceuticals, Inc.
  001-31812
  210 Main Street West
  Daudette
  MN
  56623
  218-634-3500
  Nikhil S. Lalwani
  President, CEO
  Common
  JP Morgan Securities LLC
  390 Madison Avenue
  6th Floor
  New York
  NY
  10017
  11616
  708344
  20280798
  08/15/2023
  NASDAQ
  Common
  08/15/2023
  Stock Option Exercise
  Issuer
  N
  11616
  08/15/2023
  Cash
  N
  Nikhil S. Lalwani
  C/o ANI Pharmaceuticals, Inc.
  210 Main Street West
  Daudette
  MN
  56623
  Common
  08/11/2023
  56666
  3272462
  The options to be exercised within 3 months from the date of this filing.
  08/15/2023
  /s/ J.P. Morgan Securities LLC as agent and attorney-in-fact for Nikhil S. Lalwani